- Oxypaeoniflorin
-
- $0.00 / 20mg
-
2023-02-24
- CAS:39011-91-1
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- oxypaeoniflorin
-
- $8.00 / 1kg
-
2023-02-13
- CAS:39011-91-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100MT
- oxypaeoniflorin
-
- $110.00 / 1kg
-
2023-02-13
- CAS:39011-91-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100MT
|
| | oxypaeoniflora Basic information |
| Product Name: | oxypaeoniflora | | Synonyms: | oxypaeoniflora;oxypaeoniflorin;[[(1aR)-3aβ,5,5aβ,5b-Tetrahydro-5β-hydroxy-5bβ-[[(4-hydroxybenzoyl)oxy]methyl]-2-methyl-2α,5-methano-3,4-dioxa-1H-cyclobuta[cd]pentalen]-1aβ(2H)-yl]β-D-glucopyranoside;Nsc258310;Oxypeoniflorin;Oxypaeoniflorin, >98%;β-D-Glucopyranoside, (1aR,2S,3aR,5R,5aR,5bS)-tetrahydro-5-hydroxy-5b-[[(4-hydroxybenzoyl)oxy]methyl]-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta[cd]pentalen-1a(2H)-yl;((2S,2aR,2a1S,3aR,4R,5aR)-4-hydroxy-2-methyl-2a-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-1,5-dioxa-2,4-methanocyclobuta[cd]pentalen-2a1-yl)methyl 4-hydroxybenzoate | | CAS: | 39011-91-1 | | MF: | C23H28O12 | | MW: | 496.46 | | EINECS: | | | Product Categories: | chemical reagent;pharmaceutical intermediate;phytochemical;The group of Paeoniflorin;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 39011-91-1.mol |  |
| | oxypaeoniflora Chemical Properties |
| Melting point | >162°C (dec.) | | Boiling point | 737.1±60.0 °C(Predicted) | | density | 1.71±0.1 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 8.16±0.15(Predicted) | | color | White to Pale Yellow | | Stability: | Hygroscopic |
| | oxypaeoniflora Usage And Synthesis |
| Chemical Properties | White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from peony bark, peony root, and red peony root. | | Uses | Oxypaeoniflora is a plant extract of Paeonia suffruticosa, and has been used in the prevention of pathogenesis diabetic nephropathy providing anti-oxidative and anti-inflammatory activity. | | Definition | ChEBI: Oxypaeoniflorin is a monoterpene glycoside with formula C23H28O12, isolated from several species of Paeoniae. It has a role as a plant metabolite. It is a cyclic acetal, a lactol, a bridged compound, a beta-D-glucoside, a 4-hydroxybenzoate ester and a monoterpene glycoside. | | in vivo | Oxypaeoniflorin (OPA; 10-40 mg/kg; intragastrical administration; every day; for 30 days) treatment significantly reduces disruption of cardiac function and improves the indicators of ejection fraction (EF) and fractional shortening (FS). Oxypaeoniflorin significantly reduces the release of myocardial infarction-related factors, such as the creatine kinase (CK-MB), cardiac troponin I (cTnI) and cardiac troponin T (cTnT)[1]. | Animal Model: | C57BL/6 male mice (6-8 weeks of age, 20-25 g) bearing myocardial ischemia/reperfusion (MI/R) injury[1] | | Dosage: | 10 mg/kg, 20 mg/kg, 40 mg/kg | | Administration: | Intragastrical administration; every day; for 30 days | | Result: | Significantly reduced disruption of cardiac function and improved the indicators of ejection fraction (EF) and fractional shortening (FS). |
|
| | oxypaeoniflora Preparation Products And Raw materials |
|